Patent ID: 8377912
Filing Date: 2013-02-19
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for treating a person suffering from or at risk of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes, comprising administering to a person in need thereof a preparation, comprising: a) at least 120 mg long chain polyunsaturated fatty acid fraction comprising docosahexaenoic acid (DHA); b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.